Arun N, Dev A, Singh VK. A Study on the Efficacy of 24 Weeks of Sofosbuvir, Daclatasvir with Ribaravin in the Treatment of Chronic Hepatitis C Patients with Cirrhosis, Genotype 1 and 3. AJMR [Internet]. 2019Jan.20 [cited 2024May5];7(4):ME25-ME28. Available from: https://aijournals.com/index.php/ajmr/article/view/434